GlassScriptPhysician profile
Keegan Cole
NPI 1497117568
$20,455.61
in general payments reported to CMS, 2019-2025
17 companies · $43.08 in 2025
The $43.08 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13K · 2022: $6,048 · 2023: $1,028 · 2024: $606 · 2025: $43.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,676.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $13,896.70 | 2021-2022 | |
| Acumed LLC | $3,271.81 | 2021-2023 | Acumed |
| Zimmer Biomet Holdings, INC. | $856.81 | 2022-2025 | Comprehensive Shoulder System, Persona, Xtrafix |
| Stryker Corporation | $528.37 | 2022-2024 | Dall-Miles, Gamma, Inspace |
| Skeletal Dynamics INC | $358.56 | 2022-2025 | Ijs, Geminus, Implate |
| Prodigy Surgical Distribution, INC. | $242.80 | 2022 | |
| Exsomed Corporation | $236.25 | 2022 | |
| Medacta USA, INC. | $135.98 | 2022 | |
| Solventum Corporation | $135.20 | 2024 | V.A.C. Granufoam |
| Smith+Nephew, INC. | $133.07 | 2022 | |
| Acera Surgical, INC. | $124.90 | 2024 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $123.12 | 2022 | |
| Si-Bone, INC. | $113.69 | 2022 | |
| Sonex Health, INC. | $107.39 | 2022 | |
| Axogen | $85.74 | 2023 | Avance Nerve Graft |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $84.80 | 2022 | |
| Depuy Synthes Sales INC. | $20.42 | 2023 | Na, Motoband |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keegan Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.